Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Chroma announces results from phase I study of cancer therapy CHR-2797

Dec. 17, 2007

Mitsubishi Tanabe Pharma reports positive preclinical data on novel tyrosine kinase inhibitor AV-412

Dec. 17, 2007

Genentech to initiate phase II clinical testing in 2008 of Hedgehog antagonist drug candidate

Dec. 17, 2007

Activity of obatoclax investigated in multiple studies

Dec. 17, 2007

ADAM inhibitors, a promising approach for HER2+ cancer therapy

Dec. 17, 2007

KW-2449 safe and well tolerated in phase I study in hematologic malignancies

Dec. 14, 2007

Zevalin meets primary endpoint in follicular non-Hodgkin's lymphoma trial

Dec. 14, 2007

FDA grants approval to SKCC for phase I clinical trial of breast cancer vaccine

Dec. 13, 2007

Celsion refiles for an FDA Special Protocol Assessment for phase III trial of ThermoDox

Dec. 13, 2007

BioInvent designates BI-505 for blood cancer as new drug candidate

Dec. 13, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...